Olivier Brocq Selected Research

Joint Diseases (Joint Disease)

1/2022	Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
3/2016	Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: A retrospective study.
3/2007	TNFalpha antagonist continuation rates in 442 patients with inflammatory joint disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Brocq Research Topics

Disease

13	Rheumatoid Arthritis 10/2020 - 09/2004
4	Pain (Aches) 01/2017 - 06/2002
3	Joint Diseases (Joint Disease) 01/2022 - 03/2007
3	Psoriatic Arthritis 02/2010 - 02/2007
2	Hip Osteoarthritis (Coxarthrosis) 01/2017 - 06/2002
2	Ankylosing Spondylitis 12/2012 - 03/2007
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2010 - 02/2007
2	Osteoarthritis 07/2007 - 03/2006
1	Vasculitis (Vasculitides) 01/2022
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2022
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 10/2020
1	Infections 10/2020
1	Crohn Disease (Crohn's Disease) 10/2020
1	Ulcerative Colitis 10/2020
1	Multiple Sclerosis 10/2020
1	Obesity 01/2020
1	Human Influenza (Influenza) 03/2016
1	Necrosis 01/2016
1	Skin Manifestations 02/2010
1	Tuberculosis (Tuberculoses) 02/2010
1	Spondylarthropathies 02/2007
1	Arthritis (Polyarthritis) 03/2006
1	Vascular Skin Diseases 09/2004
1	Glomerulonephritis 09/2004

Drug/Important Bio-Agent (IBA)

6	Etanercept (Enbrel)FDA Link 10/2020 - 09/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2016 - 09/2004
4	Biological ProductsIBA 01/2022 - 09/2016
4	Infliximab (Remicade)FDA Link 10/2020 - 05/2006
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 10/2020
2	VaccinesIBA 01/2022 - 03/2016
2	Tumor Necrosis Factor InhibitorsIBA 01/2020 - 01/2016
2	Prostaglandins AIBA 01/2017 - 11/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2011 - 03/2006
2	Hyaluronic Acid (Hyaluronan)IBA 07/2007 - 03/2006
1	Antirheumatic Agents (DMARD)IBA 01/2022
1	Adalimumab (Humira)FDA Link 10/2020
1	Rituximab (Mabthera)FDA Link 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	InterferonsIBA 10/2020
1	tocilizumab (atlizumab)FDA Link 10/2020
1	4-hexyloxyaniline (HOA)IBA 01/2017
1	Pharmaceutical PreparationsIBA 09/2016
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 03/2016
1	C-Reactive ProteinIBA 12/2012
1	amsonic acid (DAS)IBA 03/2012
1	SodiumIBA 07/2007
1	pneumococcal purpura-producing principle (PPPP)IBA 02/2007
1	Rheumatoid FactorIBA 02/2007
1	Azathioprine (Imuran)FDA LinkGeneric 05/2006
1	Leflunomide (Arava)FDA LinkGeneric 05/2006
1	Analgesics (Analgesic Drugs)IBA 07/2002
1	hylanIBA 06/2002

Therapy/Procedure

7	Therapeutics 10/2020 - 05/2006
3	Injections 01/2016 - 07/2007
2	Biological Therapy 10/2020 - 03/2016
2	Viscosupplementation 01/2017 - 06/2002
2	Intra-Articular Injections 03/2006 - 06/2002
1	Subcutaneous Injections 01/2020